Clinical Trial Update: Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation [Phase 2]

View source ↗

Summary

Phase 2 study to assess safety and tolerability of brincidofovir in kidney transplant recipients with BK virus infection (viremia); the trial has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Virus Infection
• Bk Virus Nephropathy

Drugs mentioned

• Brincidofovir (brincidofovir)

Snippet

Sponsor: SymBio Pharmaceuticals | Conditions: BK Virus Infection, Nephropathy | Phase 2 | Status: TERMINATED